Auchus R J, Palmer J O, Carrell H L, Covey D F
Department of Pharmacology, Washington University School of Medicine, St. Louis, MO 63110.
Steroids. 1989 Jan-Feb;53(1-2):77-96. doi: 10.1016/0039-128x(89)90147-5.
The conversion of estrone to 14,15-secoestratrien-15-ynes, inactivators of estradiol dehydrogenase from human term placenta, is described. The optically pure precursor 7-acetoxy-octahydro-2-phenanthrenecarboxylic acid methyl ester is prepared from estrone in five steps and 40% yield. The unsubstituted propargylic secoestratriene diol, a mechanism-based inactivator of estradiol dehydrogenase, and the corresponding acetylenic ketone, an affinity label inactivator of the same enzyme, arise from the phenanthrene ester in three and four steps. The propargylic secoestratriene diol also competes with [3H]estradiol for binding to calf uterus estrogen receptor and possesses weak uterotrophic activity.
本文描述了雌酮转化为14,15-断雌三烯-15-炔的过程,这些化合物是人足月胎盘雌二醇脱氢酶的失活剂。光学纯的前体7-乙酰氧基-八氢-2-菲羧酸甲酯由雌酮经五步反应制得,产率为40%。未取代的炔丙基断雌三烯二醇是一种基于机制的雌二醇脱氢酶失活剂,相应的炔酮是同一种酶的亲和标记失活剂,它们分别由菲酯经三步和四步反应得到。炔丙基断雌三烯二醇还能与[³H]雌二醇竞争结合小牛子宫雌激素受体,并具有微弱的子宫营养活性。